Nabriva Therapeutics plc — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$36.9M

Net Income/Loss (FY2022)

-$57.2M

Total Assets (FY2022)

$31.8M

Total Equity (FY2022)

$3.3M

Cash Flows from Operating Activities (FY2022)

-$36.7M

Source: Nabriva Therapeutics plc 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.